Letrozole 2.5mgs x 30ml
Indicated for the adjuvant treatment of post menopausal women with hormone receptor positive early breast cancer.
Extended adjuvant treatment of hormone-dependent early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy for 5 years
First-line treatment in post menopausal women with hormone-dependent advanced breast cancer
Advanced breast cancer in women with natural or artificially induced post menopausal status after relapse or disease progression, who have previously been treated with anti-oestrogens.
Efficacy has not been demonstrated in patients with hormone receptor negative breast cancer